Status:
COMPLETED
Effect of Olopatadine on Allergic Tear Mediators
Lead Sponsor:
University of Wisconsin, Madison
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Allergic Conjunctivitis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of the research is to determine which inflammatory substances are involved in causing allergic symptoms in the eye. Allergic conjunctivitis is a common problem with symptoms of temporary r...
Detailed Description
Ocular allergies are extremely common, affecting up to 80 million people in the USA. Our research question is: Are there differences in inflammatory mediators and cell surface activation markers in p...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Skin test positive
- Able to put drops in eyes
- Able to have tears collected
Exclusion
Key Trial Info
Start Date :
September 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00609128
Start Date
September 1 2000
End Date
November 1 2009
Last Update
September 20 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin
Madison, Wisconsin, United States, 53705